These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Solriamfetol treatment of excessive daytime sleepiness in participants with narcolepsy or obstructive sleep apnea with a history of depression. Krystal AD; Benca RM; Rosenberg R; Schweitzer PK; Malhotra A; Babson K; Lee L; Bujanover S; Strohl KP J Psychiatr Res; 2022 Nov; 155():202-210. PubMed ID: 36070638 [TBL] [Abstract][Full Text] [Related]
45. Incidence and duration of common early-onset adverse events in randomized controlled trials of solriamfetol for treatment of excessive daytime sleepiness in obstructive sleep apnea and narcolepsy. Rosenberg R; Thorpy MJ; Dauvilliers Y; Schweitzer PK; Zammit G; Gotfried M; Bujanover S; Scheckner B; Malhotra A J Clin Sleep Med; 2022 Jan; 18(1):235-244. PubMed ID: 34283019 [TBL] [Abstract][Full Text] [Related]
46. The effects of Provent on moderate to severe obstructive sleep apnoea during continuous positive airway pressure therapy withdrawal: a randomised controlled trial. Rossi VA; Winter B; Rahman NM; Yu LM; Fallon J; Clarenbach CF; Bloch KE; Stradling JR; Kohler M Thorax; 2013 Sep; 68(9):854-9. PubMed ID: 23723343 [TBL] [Abstract][Full Text] [Related]
47. Randomized Trial on the Effects of High-Dose Zopiclone on OSA Severity, Upper Airway Physiology, and Alertness. Carter SG; Carberry JC; Grunstein RR; Eckert DJ Chest; 2020 Jul; 158(1):374-385. PubMed ID: 32197956 [TBL] [Abstract][Full Text] [Related]
48. [Diagnostic accuracy of Epworth sleepiness scale in the acute phase of myocardial infarction]. Ben Ahmed H; Boussaid H; Hamdi I; Longo S; Baccar H; Boujnah MR Rev Pneumol Clin; 2014 Jun; 70(3):142-7. PubMed ID: 24646779 [TBL] [Abstract][Full Text] [Related]
49. Uncovering the sleep disorders among young doctors. Yasin R; Muntham D; Chirakalwasan N Sleep Breath; 2016 Dec; 20(4):1137-1144. PubMed ID: 27535070 [TBL] [Abstract][Full Text] [Related]
50. The effect of cognitive and behavioral therapy for insomnia on week-to-week changes in sleepiness and sleep parameters in patients with comorbid insomnia and sleep apnea: a randomized controlled trial. Sweetman A; McEvoy RD; Smith S; Catcheside PG; Antic NA; Chai-Coetzer CL; Douglas J; O'Grady A; Dunn N; Robinson J; Paul D; Williamson P; Lack L Sleep; 2020 Jul; 43(7):. PubMed ID: 31927569 [TBL] [Abstract][Full Text] [Related]
51. [Association between residual sleepiness and central sleep apnea events in patients with obstructive sleep apnea syndrome]. Yao SM; Zhang XL Zhonghua Jie He He Hu Xi Za Zhi; 2008 Sep; 31(9):664-9. PubMed ID: 19080566 [TBL] [Abstract][Full Text] [Related]
52. Safety and pharmacodynamics of a single infusion of danavorexton in adults with obstructive sleep apnea experiencing excessive daytime sleepiness despite adequate use of CPAP. Bogan RK; Maynard JP; Neuwirth R; Faessel H; Swick T; Olsson T Sleep Med; 2023 Jul; 107():229-235. PubMed ID: 37244138 [TBL] [Abstract][Full Text] [Related]
53. Modafinil in the treatment of idiopathic hypersomnia without long sleep time--a randomized, double-blind, placebo-controlled study. Mayer G; Benes H; Young P; Bitterlich M; Rodenbeck A J Sleep Res; 2015 Feb; 24(1):74-81. PubMed ID: 25196321 [TBL] [Abstract][Full Text] [Related]
54. Associations of Undiagnosed Obstructive Sleep Apnea and Excessive Daytime Sleepiness With Depression: An Australian Population Study. Lang CJ; Appleton SL; Vakulin A; McEvoy RD; Vincent AD; Wittert GA; Martin SA; Grant JF; Taylor AW; Antic N; Catcheside PG; Adams RJ J Clin Sleep Med; 2017 Apr; 13(4):575-582. PubMed ID: 28095971 [TBL] [Abstract][Full Text] [Related]
55. Inverse relationship of subjective daytime sleepiness to sympathetic activity in patients with heart failure and obstructive sleep apnea. Taranto Montemurro L; Floras JS; Millar PJ; Kasai T; Gabriel JM; Spaak J; Coelho FMS; Bradley TD Chest; 2012 Nov; 142(5):1222-1228. PubMed ID: 23303285 [TBL] [Abstract][Full Text] [Related]
56. Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Arzt M; Young T; Finn L; Skatrud JB; Ryan CM; Newton GE; Mak S; Parker JD; Floras JS; Bradley TD Arch Intern Med; 2006 Sep; 166(16):1716-22. PubMed ID: 16983049 [TBL] [Abstract][Full Text] [Related]
57. Depressive symptoms are associated with poor sleep quality rather than apnea-hypopnea index or hypoxia during sleep in patients with obstructive sleep apnea. Lee SH; Lee YJ; Kim S; Choi JW; Jeong DU Sleep Breath; 2017 Dec; 21(4):997-1003. PubMed ID: 28825197 [TBL] [Abstract][Full Text] [Related]
58. Placebo response in objective and subjective measures of hypersomnia in randomized clinical trials on obstructive sleep apnea. A systematic review and meta-analysis. Labarca G; Montenegro R; Oscullo G; Henriquez-Beltran M; Uribe JP; Gómez-Olivas JD; Garcia-Ortega A; Martínez-García MÁ Sleep Med Rev; 2023 Feb; 67():101720. PubMed ID: 36495752 [TBL] [Abstract][Full Text] [Related]
59. [Risk for sleep apnea syndrome and excessive daily sleepiness in chronic hemodialysis patients]. Zibar L; Kristić A; Krnjeta D; Dogas Z Acta Med Croatica; 2011 Oct; 65 Suppl 3():30-5. PubMed ID: 23120812 [TBL] [Abstract][Full Text] [Related]
60. Can we use serum copeptin levels as a biomarker in obstructive sleep apnea syndrome? Selcuk OT; Eyigor M; Renda L; Osma U; Eyigor H; Selcuk NT; Yılmaz MD; Demirkıran C; Unlu H; Gültekin M J Craniomaxillofac Surg; 2015 Jul; 43(6):879-82. PubMed ID: 25957103 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]